Money
Eminetra Money News: Check the latest news on US Stock market, IPO, personal finance, financial investment, real estate, and top banking sector at Eminetra.com
-
Netflix Gives Its Toughest Audience What It Wants
In a way, Netflix NFLX -1.26% might soon find out just how critic-proof it really is. The streaming giant is…
Read More » -
Activision, Apple, Tesla, Goldman Sachs: What to Watch When the Stock Market Opens Today
Wall Street stock indexes dropped in morning trading, with tech stocks leading losses. Government bond yields are climbing as investors…
Read More » -
Microsoft to Buy Activision Blizzard in All-Cash Deal Valued at $68.7 Billion
A Microsoft office in Mountain View, Calif. Photo: David Paul Morris/Bloomberg News Updated Jan. 18, 2022 8:55 am ET Microsoft…
Read More » -
Omicron’s Impact on Oil Demand Weaker Than Expected in Late 2021
The 2022 world oil demand growth forecast remains steady, OPEC said on Tuesday. Photo: saudi aramco handout/Shutterstock Demand for oil…
Read More » -
With Rate Increases Looming, Investors Dump Shares of Money-Losing Companies
Moonshot stocks are coming back to Earth. As the Federal Reserve moves closer to raising interest rates, investors are repricing…
Read More » -
Citigroup Nears Sale of Taiwan Consumer-Banking Business
HONG KONG— Citigroup Inc. C -1.25% is nearing a sale of its retail banking franchise in Taiwan to DBS Group…
Read More » -
Stock Futures Decline After Holiday Break
Jan. 18, 2022 3:35 am ET U.S. stock futures slipped, with big technology shares on track to lead losses when…
Read More » -
BlackRock’s Climate Stance Is About Profits, Not Politics, Larry Fink Says
In his annual letter to the CEOs of the companies in which BlackRock invests, Mr. Fink said businesses that don’t…
Read More » -
Credit Suisse Shows Flaws of Trying to Quantify ESG Risks
Wall Street’s hottest investment trend is to score companies on environmental, social and governance criteria, in an attempt to steer…
Read More » -
Unilever’s $68 Billion Health Kick Is the Wrong Remedy
Unilever’s UL 1.14% bid for GlaxoSmithKline’s GSK 0.91% majority-owned consumer-health business is a bold move from a management team sometimes…
Read More »